ArticleBreast cancer research and treatment2025

Clinical, sociodemographic, and facility-related determinants of immunotherapy use in metastatic triple-negative breast cancer.

Ismail Ajjawi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.